117 related articles for article (PubMed ID: 6161895)
1. The antihypertensive effect of captopril. Evidence for an influence of kinins.
Mimran A; Targhetta R; Laroche B
Hypertension; 1980; 2(6):732-7. PubMed ID: 6161895
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor.
Fagard RH; Amery AK; Lijnen PJ; Reybrouck TM
Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the acute effect of a converting enzyme inhibitor, captopril, in normal and hypertensive subjects].
Mimran A; Laroche B; Targhetta R; Roumieux JL
Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():61-5. PubMed ID: 6794529
[TBL] [Abstract][Full Text] [Related]
4. Altered blood pressure and renin responses to converting enzyme inhibition after aprotinin-induced kallikrein-kinin-system blockade.
Overlack A; Stumpe KO; Kühnert M; Heck I
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():129s-132s. PubMed ID: 6160938
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system.
Filep J; Rigter B; Földes-Filep E
J Cardiovasc Pharmacol; 1987 Aug; 10(2):222-7. PubMed ID: 2441174
[TBL] [Abstract][Full Text] [Related]
6. Circulatory effects of renin-angiotensin system antagonists during halothane anaesthesia in hypertensive rats.
Kaukinen S; Kataja J; Ylitalo P
Acta Anaesthesiol Scand; 1983 Feb; 27(1):81-6. PubMed ID: 6340406
[TBL] [Abstract][Full Text] [Related]
7. [Acute antihypertensive effect of captopril in hypertensive patients: with special reference to kallikrein-kinin system].
Mizuno K; Gotoh M; Haruyama K; Hashimoto S; Toki T; Matsui J; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1620-9. PubMed ID: 6363144
[TBL] [Abstract][Full Text] [Related]
8. Evidence for participation of kinins in the antihypertensive effect of converting enzyme inhibition.
Overlack A; Stumpe KO; Kühnert M; Kolloch R; Ressel C; Heck I; Krück F
Klin Wochenschr; 1981 Jan; 59(2):69-74. PubMed ID: 6163004
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the role of kinins in the acute antihypertensive effect of captopril in low-renin hypertension.
Mizuno K; Haruyama K; Gotoh M; Matsui J; Fukuchi S
Jpn Heart J; 1984 May; 25(3):379-86. PubMed ID: 6381785
[TBL] [Abstract][Full Text] [Related]
10. The kallikrein-kinin system in blood pressure homeostasis.
Lee TC; Kushiro T; Gassia JP; Girolami JP; Lupu AN; Maxwell MH
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():255s-258s. PubMed ID: 94277
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A
Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597
[TBL] [Abstract][Full Text] [Related]
12. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
13. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
Chen K; Zhang X; Dunham EW; Zimmerman BG
Hypertension; 1996 Jan; 27(1):85-9. PubMed ID: 8591894
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor.
Sullivan JM; Ginsburg BA; Ratts TE; Johnson JG; Barton BR; Kraus DH; McKinstry DN; Muirhead EE
Hypertension; 1979; 1(4):397-401. PubMed ID: 232084
[TBL] [Abstract][Full Text] [Related]
15. Effect of aprotinin-induced kallikrein inhibition on the cardiovascular and renal action of captopril in diuretic-treated dogs.
Vemulapalli S; Chiu PJ
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):109-23. PubMed ID: 6191727
[TBL] [Abstract][Full Text] [Related]
16. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
17. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
18. Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity.
Waeber B; Gavras I; Brunner HR; Cook CA; Charocopos F; Gavras HP
Am Heart J; 1982 Mar; 103(3):384-90. PubMed ID: 6278905
[TBL] [Abstract][Full Text] [Related]
19. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats.
Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184
[TBL] [Abstract][Full Text] [Related]
20. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
